Literature DB >> 6819618

Sleep apnea considered as a control system instability.

G S Longobardo, B Gothe, M D Goldman, N S Cherniack.   

Abstract

In the present study a mathematical model of the chemical control of respiration is described which attempts to simulate periodic breathing during sleep. The model is an extension of an earlier model which has been shown to successfully reproduce the transient effects of CO2 inhalation on breathing, controlled changes in ventilation on arterial gas tension, and Cheyne-Stokes breathing. Included in the extended model are the effects of chemical stimuli during sleep on both chest wall and upper airway muscle activity. Data is presented indicating that simulations from the model reproduce reasonably well the essential features of the results obtained in eight subjects with periodic respiration during sleep when breathing room air, O2, or low concentrations of CO2. Simulations from the model and the experimental data suggest that periodic breathing during sleep results from unstable operation in the respiratory control system analogous to that seen during instabilities in physical control systems. The model indicates that obstructive as well as central apneas can be produced by control system instability. Furthermore, central apneas increase the likelihood of obstructive apneas while obstructive apneas tend to aggravate the control instability. The model results predict that the characteristics of the periodic breathing seen during sleep, such as apnea length, will depend on circulation time and the sensitivity of both upper airway and chest wall muscles to hypercapnia and hypoxia.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6819618     DOI: 10.1016/0034-5687(82)90026-3

Source DB:  PubMed          Journal:  Respir Physiol        ISSN: 0034-5687


  32 in total

1.  Stabilizing ventilation in OSAHS with CPAP emergent periodic breathing through the use of dead space.

Authors:  David M Rapoport
Journal:  J Clin Sleep Med       Date:  2010-12-15       Impact factor: 4.062

Review 2.  The pathogenesis of obstructive sleep apnea.

Authors:  Luu V Pham; Alan R Schwartz
Journal:  J Thorac Dis       Date:  2015-08       Impact factor: 2.895

Review 3.  Causes of Cheyne-Stokes respiration.

Authors:  N S Cherniack; G Longobardo; C J Evangelista
Journal:  Neurocrit Care       Date:  2005       Impact factor: 3.210

4.  Cluster analysis: A new technology for the evaluation of oximetry and airflow waveforms in obstructive sleep apnea.

Authors:  L A Lynn
Journal:  Sleep Breath       Date:  1997-12       Impact factor: 2.816

5.  Carotid body tumors are not associated with an increased risk for sleep-disordered breathing.

Authors:  L T van Hulsteijn; N van Duinen; M K Ninaber; J A Romijn; J G van Dijk; K W van Kralingen; B Havekes; L Smid; G J Lammers; J C Jansen; J W Smit; R D Thijs; E P M Corssmit
Journal:  Sleep Breath       Date:  2013-05-09       Impact factor: 2.816

Review 6.  Epidemiology of Sleep-Disordered Breathing and Heart Failure: What Drives What.

Authors:  Sushma M Dharia; Lee K Brown
Journal:  Curr Heart Fail Rep       Date:  2017-10

7.  CO2 control of the respiratory system: plant dynamics and stability analysis.

Authors:  A elHefnawy; G M Saidel; E N Bruce
Journal:  Ann Biomed Eng       Date:  1988       Impact factor: 3.934

8.  Improvement of idiopathic central sleep apnea with zolpidem.

Authors:  Syed Quadri; Christopher Drake; David W Hudgel
Journal:  J Clin Sleep Med       Date:  2009-04-15       Impact factor: 4.062

9.  A measure of ventilatory variability at wake-sleep transition predicts sleep apnea severity.

Authors:  Lamia H Ibrahim; Sanjay R Patel; Mohammad Modarres; Nathan L Johnson; Reena Mehra; H Lester Kirchner; Susan Redline
Journal:  Chest       Date:  2008-03-17       Impact factor: 9.410

10.  Ventilatory control and airway anatomy in obstructive sleep apnea.

Authors:  Andrew Wellman; Amy S Jordan; Atul Malhotra; Robert B Fogel; Eliot S Katz; Karen Schory; Jill K Edwards; David P White
Journal:  Am J Respir Crit Care Med       Date:  2004-08-18       Impact factor: 21.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.